S100A9 and Parkinson disease: We suggest here that sustained neuroinflammation promoting the spread of amyloidogenic S100A9 in the brain tissues can be a trigger of the amyloid cascade involving α-syn and leading to PD development [11], similar to the effect of S100A9 on Aβ aggregation in the Alzheimer’s disease [18].